🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/01/2012 | 7,62 | 7,64 | 7,52 | 7,64 | -0,16% | 1,64% | 55.945 |
| 20/01/2012 | 7,52 | 7,65 | 7,44 | 7,65 | +1,49% | 2,82% | 44.884 |
| 19/01/2012 | 7,62 | 7,62 | 7,45 | 7,54 | -1,15% | 2,21% | 94.898 |
| 18/01/2012 | 7,47 | 7,65 | 7,45 | 7,62 | +2,00% | 2,59% | 66.204 |
| 17/01/2012 | 7,61 | 7,67 | 7,43 | 7,47 | -0,91% | 3,12% | 59.471 |
| 13/01/2012 | 7,40 | 7,55 | 7,39 | 7,54 | +1,00% | 2,27% | 62.036 |
| 12/01/2012 | 7,56 | 7,56 | 7,37 | 7,47 | -1,24% | 2,47% | 61.235 |
| 11/01/2012 | 7,40 | 7,57 | 7,29 | 7,56 | +1,76% | 3,88% | 103.714 |
| 10/01/2012 | 7,24 | 7,44 | 7,18 | 7,43 | +3,47% | 3,53% | 143.308 |
| 09/01/2012 | 7,27 | 7,38 | 7,16 | 7,18 | -0,69% | 3,00% | 141.224 |
| 06/01/2012 | 7,25 | 7,29 | 7,20 | 7,23 | -0,26% | 1,29% | 102.432 |
| 05/01/2012 | 7,22 | 7,32 | 7,14 | 7,25 | -0,26% | 2,51% | 75.662 |
| 04/01/2012 | 7,39 | 7,44 | 7,26 | 7,27 | -2,18% | 2,45% | 46.968 |
| 03/01/2012 | 7,49 | 7,54 | 7,37 | 7,43 | +0,34% | 2,33% | 91.371 |
| 30/12/2011 | 7,39 | 7,46 | 7,36 | 7,40 | -0,17% | 1,43% | 118.301 |
| 29/12/2011 | 7,37 | 7,49 | 7,36 | 7,42 | +1,02% | 1,86% | 81.112 |
| 28/12/2011 | 7,59 | 7,59 | 7,29 | 7,34 | -2,97% | 3,87% | 118.301 |
| 27/12/2011 | 7,36 | 7,62 | 7,34 | 7,57 | +2,88% | 3,90% | 125.836 |
| 23/12/2011 | 7,47 | 7,51 | 7,32 | 7,36 | -1,09% | 2,59% | 93.295 |
| 22/12/2011 | 7,62 | 7,69 | 7,36 | 7,44 | -2,45% | 4,42% | 169.117 |
| 21/12/2011 | 7,50 | 7,64 | 7,40 | 7,62 | +1,83% | 3,24% | 132.408 |
| 20/12/2011 | 7,40 | 7,54 | 7,40 | 7,49 | +3,01% | 1,77% | 157.254 |
| 19/12/2011 | 7,42 | 7,62 | 7,21 | 7,27 | -1,69% | 5,55% | 221.054 |
| 16/12/2011 | 7,23 | 7,40 | 6,97 | 7,39 | +3,67% | 5,95% | 255.358 |
| 15/12/2011 | 7,08 | 7,17 | 6,94 | 7,13 | +1,42% | 3,35% | 83.035 |
| 14/12/2011 | 7,16 | 7,19 | 6,94 | 7,03 | -2,76% | 3,40% | 144.110 |
| 13/12/2011 | 7,42 | 7,47 | 7,22 | 7,23 | -1,86% | 3,36% | 199.253 |
| 12/12/2011 | 7,60 | 7,60 | 7,24 | 7,37 | -3,75% | 4,84% | 191.879 |
| 09/12/2011 | 7,36 | 7,70 | 7,34 | 7,65 | +4,07% | 5,00% | 209.672 |
| 08/12/2011 | 7,31 | 7,42 | 7,23 | 7,36 | +0,00% | 2,65% | 196.528 |